Avalo Therapeutics, Inc. (AVTX) stock
Close on Nov 13, 2026Market cap $416.17MP/E –Yield –
Avalo Therapeutics statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 22, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.98
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 199.7%
- 10.8%
- Shares Change (QoQ)
- 1.93%
- 0.49%
- Float
- 53M
- 49M
- Shares Held by Insiders
- 0.71%
- 11.6%
- Shares Held by Institutions
- 135.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 9M
- –
- Short Interest Change
- -25.5%
- -0.80%
- Short % of Float
- 16.7%
- 8.98%
- Short % of Shares Outstanding
- 16.6%
- 6.30%
- Days to Cover
- 2.09
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $24.27
- –
- 52-Week Low
- $6.53
- –
- 20-Day Moving Average
- $7.97
- –
- 50-Day Moving Average
- $12.33
- –
- 200-Day Moving Average
- $15.63
- –
- Average True Range (14)
- $0.86
- –
- Price Change (1 Week)
- 12.0%
- -1.15%
- Price Change (1 Month)
- -35.4%
- -4.86%
- Price Change (3 Months)
- -61.1%
- -21.1%
- Price Change (6 Months)
- -56.3%
- -20.7%
- Price Change (YTD)
- -57.3%
- -23.6%
- Price Change (1 Year)
- -49.7%
- -22.7%
- Price Change (3 Years)
- -67.3%
- -29.5%
- Price Change (5 Years)
- -99.9%
- -77.8%
- Price Change (10 Years)
- -99.9%
- -65.4%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.66
- 0.70
- Relative Strength Index (14)
- 38.3
- 43.4
- Volatility (1 Year)
- 91.6%
- 80.1%
- Beta (5 Years)
- 0.87
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -33.6%
- -50.3%
- Return on Assets (ROA)
- -29.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -20.9%
- -38.0%
Financial positionIndustry
- Current Ratio
- 16.63
- 3.30
- Quick Ratio
- 19.21
- 2.39
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -85.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- -61.2%
- 6.41%
EfficiencyIndustry
- Profits Per Employee
- -$3.85M
- -$690.06K
- Employee Count
- 23
- 75
- WACC
- 9.44%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$88.49M
- -$12.98M
Balance sheetIndustry
- Net Cash (Debt)
- $462.80M
- $17.80M
- Net Cash Per Share
- $8.63
- $0.80
- Equity (Book Value)
- $436.55M
- $53.27M
- Book Value Per Share
- $8.14
- $1.50
- Tangible Book Value
- $426.04M
- $26.82M
- Working Capital
- $376.64M
- $79.93M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -21.3%
- -22.0%
Taxes and interestIndustry
- Income Tax
- $167.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 4.32
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AVTX | S&P 500 | Difference | AVTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -35.4% | -3.0% | −32.3 pts | ||
| 3 months | -60.1% | -2.8% | −57.3 pts | ||
| Year to date | -57.3% | +11.5% | −68.8 pts | ||
| 1 year | -47.3% | +13.5% | −60.8 pts | ||
| 3 years | -64.4% | +77.7% | −142.1 pts | -29.2% | +21.1% |
| 5 years | -99.9% | +72.6% | −172.5 pts | -74.0% | +11.5% |
| 10 years | -99.9% | +308.2% | −408.1 pts | -52.4% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
9M AVTX shares were sold short on Oct 30, 2026, down 25.5% from the previous report, or 16.73% of the shares available to trade. At recent volumes it would take 2.1 days to buy them back. Over the last 20 sessions, 32.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 8,910,655 | -25.5% | 4,261,998 | 2.1 |
| Oct 15, 2026 | 11,963,625 | +4.9% | 919,676 | 13.0 |
| Sep 30, 2026 | 11,405,304 | -11.8% | 1,296,416 | 8.8 |
| Sep 15, 2026 | 12,925,869 | +4.4% | 976,376 | 13.2 |
| Aug 31, 2026 | 12,387,012 | -5.4% | 816,596 | 15.2 |
| Aug 14, 2026 | 13,092,767 | +1.1% | 647,143 | 20.2 |
| Jul 31, 2026 | 12,950,314 | +2.1% | 900,454 | 14.4 |
| Jul 15, 2026 | 12,679,040 | +3.0% | 1,186,742 | 10.7 |
| Jun 30, 2026 | 12,307,967 | +66.0% | 2,887,428 | 4.3 |
| Jun 15, 2026 | 7,413,562 | +16.2% | 1,340,030 | 5.5 |
| May 29, 2026 | 6,382,270 | +2.1% | 1,464,002 | 4.4 |
| May 15, 2026 | 6,254,061 | +9.1% | 3,938,711 | 1.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?